Munetoyo Toda, None;
Koji Kitazawa, None;
Morio Ueno, Oncolys BioPharma Inc. (P), Santen Pharmaceutical Co., Ltd (P), Senjyu Pharmaceutical Co., Ltd (P);
Yuko Maruyama, None;
Asako Uehara, None;
Chie Sotozono, Alcon Co., Ltd. (F), Alcon Co., Ltd. (R), AMO Japan K.K. (F), HOYA Corporation (F), HOYA Corporation (R), Nitto Medic Co., Ltd. (F), Nitto Medic Co., Ltd. (R), Otsuka Pharmaceutical Co., Ltd. (F), Pfizer Inc. (F), Pfizer Inc. (R), Santen Pharmaceutical Co., Ltd. (F), Santen Pharmaceutical Co., Ltd. (R), Senju Pharmaceutical Co., Ltd. (F), Senju Pharmaceutical Co., Ltd. (R);
Junji Hamuro, Oncolys BioPharma Inc. (P);
Shigeru Kinoshita, HOYA Corporation (F), HOYA Corporation (P), KOWA Company, Ltd. (F), KOWA Company, Ltd. (P), Santen Pharmaceutical Co, Ltd. (F), Santen Pharmaceutical Co, Ltd. (P), Senjyu Pharmaceutical Co. Ltd. (F), Senjyu Pharmaceutical Co. Ltd. (P)